NASDAQ:PAVM
PAVmed Inc Stock News
$2.25
+0.0500 (+2.27%)
At Close: May 09, 2024
PAVmed Reports Preliminary First Quarter 2020 Financial Results and Provides Business Update
08:00pm, Thursday, 21'st May 2020
Conference call to be held today at 4:30 p.m. Eastern time NEW YORK, May 21, 2020 -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated,.
PAVmed, Inc. to Host Earnings Call
06:30pm, Thursday, 21'st May 2020
NEW YORK, NY / ACCESSWIRE / May 21, 2020 / PAVmed, Inc. (NASDAQ:PAVM) will be discussing their earnings results in their 2020 First Quarter Earnings call to be held on May 21, 2020 at 4:30 PM Eastern
The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive
12:00am, Thursday, 21'st May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs on May 20.)
ADC Therapeutics SA (...
IV Equipment Market Analysis as per the Latest Coronavirus Impact
03:06pm, Wednesday, 20'th May 2020
May 20, 2020 (Heraldkeepers) --
New York, May 20, 2020: You will get latest updated report as per the COVID-19 Impact on this industry. Our updated reports...
The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Earnings Flow Slows
12:00am, Sunday, 17'th May 2020
Biotech stocks had another up week, with the American Society of Gene & Stem Cell Therapy virtual conference presentations and the ASCO abstracts made available online ...
PAVmed to Hold Business Update Conference Call on May 21, 2020
01:30pm, Monday, 11'th May 2020
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the Company will host a business update confer
PAVmed Inc (NASDAQ:PAVM) Sees Large Increase in Short Interest
06:16am, Tuesday, 28'th Apr 2020
PAVmed Inc (NASDAQ:PAVM) was the recipient of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 1,760,000 shares, a growth of 36.4% from
PAVmed FDA Approval, And Other News: The Good, Bad And Ugly Of Biopharma
06:27pm, Friday, 24'th Apr 2020
PAVmed's carpal tunnel syndrome device CarpX is approved. Prothena's Parkinson's study flops, taking the stock down. Mallinckrodt's kidney failure drug applicat
Company News for Apr 22, 2020
02:12pm, Wednesday, 22'nd Apr 2020
Companies In The News Are: SYF, VXRT, PAVM, WAFD
Company News for Apr 22, 2020
02:12pm, Wednesday, 22'nd Apr 2020
Companies In The News Are: SYF, VXRT, PAVM, WAFD
PAVmed Receives FDA 510(k) Clearance for its CarpX™ Minimally Invasive Carpal Tunnel Device
01:30pm, Tuesday, 21'st Apr 2020
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced it has received 510(k) marketing clearance from the
Analysts Offer Insights on Healthcare Companies: PAVmed (PAVM), Provention Bio (PRVB) and ThermoGenesis Holdings (THMO)
11:20am, Friday, 17'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on PAVmed (PAVM), Provention Bio (PRVB) and ThermoGenesis
Edited Transcript of PAVM earnings conference call or presentation 9-Apr-20 8:30pm GMT
07:19am, Friday, 10'th Apr 2020
Q4 2019 PAVmed Inc Earnings Call
PAVmed Reports Preliminary Fourth Quarter 2019 Financial Results and Provides Business Update
08:44pm, Thursday, 09'th Apr 2020
Conference call to be held today at 4:30 p.m. Eastern time NEW YORK, April 09, 2020 -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly.
PAVmed, Inc. to Host Earnings Call
06:30pm, Thursday, 09'th Apr 2020
NEW YORK, NY / ACCESSWIRE / April 9, 2020 / PAVmed, Inc. (NASDAQ:PAVM) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on April 9, 2020 at 4:30 PM Easte
